What will the board decide at the meeting?

The board will approve the company's audited financial results for Q4 and the full year ended March 31, 2026. It will also decide whether to recommend a dividend.

Is this announcement unusual?

No. This is a standard, mandatory notice required by SEBI Listing Regulations before a company releases its financial results. The filing contains no new or material information.

What happens to the trading window?

The trading window for insiders will reopen following the board meeting and the release of the financial results, as is standard practice.

Pharmaceuticals · Micro cap

Veerhealth Care's board meets to approve FY26 results and weigh a dividend

The meeting is routine. The only question is whether the payout lands.

— 2 earlier stories on Veerhealth Care Ltd. →

NIYATILEAS By Tipsheet Editorial 25 May 2026 · 3:17 PM IST Verify on BSE · NSE

Mkt cap₹49 cr

P/E89.91×

ROE1.76%

Debt / eq.0.22

March 31, 2026 Fiscal year-end for the audited results.

What's new

Veerhealth Care's board will meet to approve Q4 and FY26 audited results.
The board will also consider recommending a dividend.
The trading window will reopen after the results are public.

Why this matters

This is a procedural notice required by SEBI before a company releases financials. It confirms the upcoming earnings release and puts a dividend on the table, but carries no new information on performance.

What we're watching

The actual FY26 numbers and dividend amount when released.
Any commentary on profitability or cash flow needed to sustain a payout.
The timeline for results publication after the board meeting.

The full read

Veerhealth Care's board is meeting to approve FY26 audited results and weigh a dividend. This is a procedural notice under SEBI rules. It is a calendar event that precedes every earnings release and contains no new information on the company's financial health or outlook. The trading window for insiders will reopen after the results are public. The only variable is the dividend. Hardly a shock. That depends on the actual FY26 numbers. Not yet.

Questions answered

What will the board decide at the meeting?: The board will approve the company's audited financial results for Q4 and the full year ended March 31, 2026. It will also decide whether to recommend a dividend.
Is this announcement unusual?: No. This is a standard, mandatory notice required by SEBI Listing Regulations before a company releases its financial results. The filing contains no new or material information.
What happens to the trading window?: The trading window for insiders will reopen following the board meeting and the release of the financial results, as is standard practice.

Mentioned: SEBI Listing Regulations · FY26 Audited Results · Dividend Recommendation

Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

Story so far

All notes on NIYATILEAS →

25 May 2026 · 3:17 PM IST Veerhealth Care's board meets to approve FY26 results and weigh a dividend
today Veerhealth lands ₹3.6 cr face-care order from undisclosed FMCG client
10d ago Veerhealth Care revenue nearly doubles to ₹32.5 cr, but Q4 slips to a loss